Please use this identifier to cite or link to this item: http://hdl.handle.net/1843/60974
Full metadata record
DC FieldValueLanguage
dc.creatorLauren Frenzel Schuchpt_BR
dc.creatorJosé Alcides Almeida de Arrudapt_BR
dc.creatorMauro Henrique Nogueira Guimarães de Abreupt_BR
dc.creatorKarolina Skarlet Silva Vianapt_BR
dc.creatorPatrícia Carlos Caldeirapt_BR
dc.creatorMaria Cássia Ferreira Aguiarpt_BR
dc.creatorVanessa Fátima Bernardespt_BR
dc.date.accessioned2023-11-14T20:34:47Z-
dc.date.available2023-11-14T20:34:47Z-
dc.date.issued2022-02-09-
dc.citation.volume36pt_BR
dc.citation.spage1pt_BR
dc.citation.epage9pt_BR
dc.identifier.doihttps://doi.org/10.1590/1807-3107bor-2022.vol36.0027pt_BR
dc.identifier.issn18073107pt_BR
dc.identifier.urihttp://hdl.handle.net/1843/60974-
dc.description.resumoTobacco smoking involves a high risk of human malignancies, including oral cancer, because it contains multiple carcinogens that cause genetic instability. Thus, a worse prognosis would be expected for cancer patients who are smokers. The aim of this study was to assess the DNA damage response through the expression of checkpoint kinase 2 (CHK2), H2A histone family member X (H2AX), and P53 among smokers and non-smokers with oral squamous cell carcinoma (OSCC). Associations between immunoexpression of proteins and clinicopathological data and histopathological grading were also analyzed. A total of 35 individuals (18 non-smokers and 17 smokers) with OSCC of the tongue and/or floor of the mouth were included. Immunohistochemistry for H2AX was conducted for the identification of double-strand breaks, CHK2, and P53 to evaluate the expression of this protein in cell cycle regulation. The sample consisted of 22 males and 13 females, with a mean age of 63.9±11.8 years. OSCC of non-smokers were well-differentiated tumors in 50% of the cases, and those of smokers were equally distributed into moderately differentiated and poorly differentiated tumors (35.3% each). Overall, 31 (88.6%) cases were CHK2-positive, 27 (77.1%) were H2AX-positive, and 23 (65.7%) were P53-positive, with no difference between smokers and non-smokers (p > 0.05). No association was found between proteins and clinicopathologic data (p > 0.05). Similarities in CHK2, H2AX, and P53 immunohistochemical staining patterns were observed between smokers and non-smokers, and immunoexpression was not associated with clinicopathological parameters. However, the findings indicated consistent expression of these proteins in OSCC.pt_BR
dc.description.sponsorshipCAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível Superiorpt_BR
dc.format.mimetypepdfpt_BR
dc.languageengpt_BR
dc.publisherUniversidade Federal de Minas Geraispt_BR
dc.publisher.countryBrasilpt_BR
dc.publisher.departmentFAO - DEPARTAMENTO DE ODONTOLOGIA SOCIAL E PREVENTIVApt_BR
dc.publisher.departmentICB - DEPARTAMENTO DE PATOLOGIApt_BR
dc.publisher.initialsUFMGpt_BR
dc.relation.ispartofBrazilian Oral Researchpt_BR
dc.rightsAcesso Abertopt_BR
dc.subjectDNA damagept_BR
dc.subjectCheckpoint kinase 2pt_BR
dc.subjectTumor suppressor protein p53pt_BR
dc.subjectMouth neoplasmspt_BR
dc.subject.otherNeoplasias bucaispt_BR
dc.subject.otherDano ao DNApt_BR
dc.subject.otherTabagismopt_BR
dc.titleDNA damage-related proteins in smokers and non-smokers with oral cancerpt_BR
dc.typeArtigo de Periódicopt_BR
dc.url.externahttps://www.scielo.br/j/bor/a/Hj5J5tHLyL4zfTMJyHzWGvD/?lang=enpt_BR
dc.identifier.orcidhttps://orcid.org/0000-0001-8794-5725pt_BR
Appears in Collections:Artigo de Periódico

Files in This Item:
File Description SizeFormat 
DNA damage-related proteins in smokers and non-smokers with oral cancer.pdf581.04 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.